AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADULT SOFT-TISSUE SARCOMAS
Authors: OBYRNE K STEWARD WP
Citation: K. Obyrne et Wp. Steward, THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADULT SOFT-TISSUE SARCOMAS, Critical reviews in oncology/hematology, 27(3), 1998, pp. 221-227
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS
Authors: STEWARD WP VONPAWEL J GATZEMEIER U WOLL P THATCHER N KOSCHEL G CLANCY L VERWEIJ J DEWIT R PFEIFER W FENNELLY J VONEIFF M FRISCH J
Citation: Wp. Steward et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS, Journal of clinical oncology, 16(2), 1998, pp. 642-650
SEOCALCITOL (EB-1089), A VITAMIN-D ANALOG, IN HEPATOCELLULAR-CARCINOMA
Authors: DALHOFF K ASTRUP L BACHHANSEN J BURCHARTH F HAAHR HLO HAMBERG KJ EVANS TRJ LOFTS F MOLLER S RANEK L SKOVSGAARD T STEWARD WP
Citation: K. Dalhoff et al., SEOCALCITOL (EB-1089), A VITAMIN-D ANALOG, IN HEPATOCELLULAR-CARCINOMA, Hepatology, 28(4), 1998, pp. 257-257
COMBINED CISPLATIN AND GEMCITABINE FOR NONSMALL CELL LUNG-CANCER - INFLUENCE OF SCHEDULING ON TOXICITY AND DRUG-DELIVERY
Authors: ABRATT RP SANDLER A CRINO L STEWARD WP SHEPHERD FA GREEN MR NGUYEN B PETERS GJ
Citation: Rp. Abratt et al., COMBINED CISPLATIN AND GEMCITABINE FOR NONSMALL CELL LUNG-CANCER - INFLUENCE OF SCHEDULING ON TOXICITY AND DRUG-DELIVERY, Seminars in oncology, 25(4), 1998, pp. 35-43
COMBINATION STUDIES WITH GEMCITABINE IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
Authors: STEWARD WP
Citation: Wp. Steward, COMBINATION STUDIES WITH GEMCITABINE IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 78, 1998, pp. 15-19
PHASE I II DOSE ESCALATING STUDY OF GEMCITABINE AND PACLITAXEL IN NONSMALL CELL LUNG-CANCER (NSCLC) - PRELIMINARY-REPORT/
Authors: OBYRNE KJ BEARE S SHIELDS F SHARMA R JEYAPALAN K STEWARD WP
Citation: Kj. Obyrne et al., PHASE I II DOSE ESCALATING STUDY OF GEMCITABINE AND PACLITAXEL IN NONSMALL CELL LUNG-CANCER (NSCLC) - PRELIMINARY-REPORT/, British Journal of Cancer, 78, 1998, pp. 24-24
PLASMA-FREE IRON AND CHEMOTHERAPY TOXICITY
Authors: BEARE S STEWARD WP
Citation: S. Beare et Wp. Steward, PLASMA-FREE IRON AND CHEMOTHERAPY TOXICITY, Lancet, 347(8998), 1996, pp. 342-343
PHASE I II STUDY OF GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS/
Authors: STEWARD WP DUNLOP DJ DABOUIS G LACROIX H TALBOT D
Citation: Wp. Steward et al., PHASE I II STUDY OF GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 23(5), 1996, pp. 43-47
AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN IM
Citation: Tl. Holyoake et al., AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 162-162
EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW
Authors: HOLYOAKE TL FRESHNEY MG MCNAIR L PARKER AN MCKAY PJ STEWARD WP FITZSIMONS E GRAHAM GJ PRAGNELL IB
Citation: Tl. Holyoake et al., EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW, Blood, 87(11), 1996, pp. 4589-4595
HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC SUPPORT FOR BREAST-CANCER
Authors: STEWARD WP
Citation: Wp. Steward, HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC SUPPORT FOR BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 21-24
IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE FOR GOOD PROGNOSIS SMALL-CELL LUNG-CANCER - ARE 4 COURSES INADEQUATE
Authors: HATTON MQF CASSIDY J BICKNELL S SEMPLE P STACK B STEWARD WP
Citation: Mqf. Hatton et al., IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE FOR GOOD PROGNOSIS SMALL-CELL LUNG-CANCER - ARE 4 COURSES INADEQUATE, European journal of cancer, 31A(6), 1995, pp. 1022-1023
DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS
Authors: STEWARD WP VONPAWEL J GATZEMEIER U THATCHER N FRISCH J
Citation: Wp. Steward et al., DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS, European journal of cancer, 31A, 1995, pp. 80-80
GEMCITABINE COMBINED WITH CISPLATIN IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE I II STUDY/
Authors: STEWARD WP DUNLOP DJ CAMERON C TALBOT DC KLEISBAUER JL THOMAS P GUERIN JC PEROL M SANSON C DABOUIS G LACROIX H
Citation: Wp. Steward et al., GEMCITABINE COMBINED WITH CISPLATIN IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE I II STUDY/, European journal of cancer, 31A, 1995, pp. 1081-1081
A SINGLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED DOSE-FINDING STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) IN PATIENTS UNDERGOING CHEMOTHERAPY FOR SOLID CANCERS AND LYMPHOMA
Authors: SEYMOUR AM DECAMPOS E THATCHER N DEGREVE J CUNNINGHAM D HOWELL A TUENI E BRON DG STEWARD WP BERDEL WE KNUTH A LORENZ J TIMOTHY AR YVER A RICHARDS MA
Citation: Am. Seymour et al., A SINGLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED DOSE-FINDING STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) IN PATIENTS UNDERGOING CHEMOTHERAPY FOR SOLID CANCERS AND LYMPHOMA, European journal of cancer, 31A(13-14), 1995, pp. 2157-2163
NEPHROGENIC DIABETES-INSIPIDUS FOLLOWING HIGH-DOSE EPIRUBICIN CHEMOTHERAPY FOR METASTATIC SOFT-TISSUE SARCOMA
Authors: VASEY PA DUNLOP DJ STEWARD WP
Citation: Pa. Vasey et al., NEPHROGENIC DIABETES-INSIPIDUS FOLLOWING HIGH-DOSE EPIRUBICIN CHEMOTHERAPY FOR METASTATIC SOFT-TISSUE SARCOMA, European journal of cancer, 31A(1), 1995, pp. 126-126
COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS OF ANONGOING PHASE I II STUDY/
Authors: STEWARD WP DUNLOP DJ CAMERON C TALBOT DC KLEISBAUER JP THOMAS P GUERIN JC PEROL M SANSON C DABOUIS G LACROIX H
Citation: Wp. Steward et al., COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS OF ANONGOING PHASE I II STUDY/, Anti-cancer drugs, 6, 1995, pp. 33-37
THE ROLE OF VINDESINE IN ONCOLOGY - RECOMMENDATIONS AFTER 10 YEARS EXPERIENCE
Authors: DANCEY J STEWARD WP
Citation: J. Dancey et Wp. Steward, THE ROLE OF VINDESINE IN ONCOLOGY - RECOMMENDATIONS AFTER 10 YEARS EXPERIENCE, Anti-cancer drugs, 6(5), 1995, pp. 625-636
NEW DRUGS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
Authors: STEWARD WP DUNLOP DJ
Citation: Wp. Steward et Dj. Dunlop, NEW DRUGS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 6, 1995, pp. 49-54
DIDEMNIN-B IN FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP
Authors: GOSS G MULDAL A LOHMANN R TAYLOR M LOPEZ P ARMITAGE G STEWARD WP
Citation: G. Goss et al., DIDEMNIN-B IN FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Investigational new drugs, 13(3), 1995, pp. 257-260
CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN IM
Citation: Mj. Alcorn et al., CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC, Blood, 86(10), 1995, pp. 907-907
A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN JM
Citation: Tl. Holyoake et al., A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE, Blood, 86(10), 1995, pp. 1161-1161
EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING (VOL 12, PG 114-124, 1994)
Authors: HOLYOAKE TL ALCORN MJ RICHMOND LJ FRESHNEY MG PEARSON C FITZSIMONS E STEWARD WP DUNLOP DJ PRAGNELL IB
Citation: Tl. Holyoake et al., EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING (VOL 12, PG 114-124, 1994), Stem cells, 12(2), 1994, pp. 233-233
EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING
Authors: HOLYOAKE TL ALCORN MJ RICHMOND LJ FRESHNEY MG PEARSON C FITZSIMONS E STEWARD WP DUNLOP DJ PRAGNELL IB
Citation: Tl. Holyoake et al., EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING, Stem cells, 12(1), 1994, pp. 114-124
A PHASE I-II STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ADDEDTO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER
Authors: JODRELL DI OSTER W KERR DJ CANNEY PA YOSEF H STEWARD WP KAYE SB CASSIDY J
Citation: Di. Jodrell et al., A PHASE I-II STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ADDEDTO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 30A(7), 1994, pp. 950-954
Risultati: 1-25 | 26-39